Orbimed Advisors - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 53 filers reported holding CYTEK BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q4 2021$31,386,000
-23.8%
1,923,1390.0%0.40%
-10.8%
Q3 2021$41,174,0001,923,1390.45%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,100,000$30,912,00012.48%
Miura Global Management 820,000$12,070,0007.24%
RA Capital Management 13,381,054$196,969,0004.20%
HHLR ADVISORS, LTD. 8,757,030$128,903,0003.39%
Brown Capital Management 4,406,461$64,863,0000.91%
Perceptive Advisors 1,289,534$18,982,0000.55%
Hillsdale Investment Management Inc. 344,529$5,072,0000.46%
PURA VIDA INVESTMENTS, LLC 527,164$7,760,0000.45%
Parkwood LLC 42,336$623,0000.09%
PDT Partners, LLC 31,436$463,0000.07%
View complete list of CYTEK BIOSCIENCES INC shareholders